| Name | Title | Contact Details |
|---|
Bottom Line Benefits is a Acworth, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
eStudySite is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NEXGEL Advanced Hydrogel Solutions in a manufacturer of unique trans-dermal delivery system that was originally developed and FDA-approved for the Hospital Wound Care market, and is now being deployed against Consumer OTC, Rx, Medical Device and Cosmetic applications.
Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.
Since 1968 our goal has been straightforward: help patients get their life back on track and achieve a life of sobriety, free from drug use and symptoms of mental illness. A life that is productive, socially responsible and healthy. Gateway Foundation is one of the nation`s largest nonprofit provider of substance use disorder treatment and a nationally recognized leader in the field of addiction medicine. With treatment programs in Florida, Georgia, Illinois, Michigan, Missouri, New Jersey, Texas and Wyoming we specialize in substance use disorders for patients diagnosed with substance use disorder and mental health disorders. Gateway Foundation`s professional clinicians support over 9,000 people a day to successfully complete treatment by developing a personalized plan to treat the underlying causes of substance use disorder—not just their addiction to drugs or alcohol.